November 3, 2025—Endovascular Engineering, Inc. (E2) announced positive results from the pivotal cohort of the ENGULF investigational device exemption (IDE) study evaluating the Hēlo thrombectomy ...

Micro Interventional Devices Receives FDA Approval of the STTAR-US IDE Pivotal Trial for its MIA™-T Percutaneous Tricuspid Annuloplasty System Micro Interventional Devices (MID), a pioneering company ...

First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY ...

BOISE, Idaho — St. Luke's Health System has a new look, including an updated logo and redesigned website. The health system released its new website and logo on Sept. 17 in an effort to align with its ...

The first “Peanuts” comic strip by Charles M. Schulz was published in seven newspapers on Oct. 2, 1950. To celebrate the 75th anniversary of the comic that spawned television specials, movies and ...

A spectacular partial solar eclipse will be visible across a swathe of the southern hemisphere this week. On Sept. 21-22, a partial solar eclipse will see the moon sweep over the sun's disk, blocking ...

Pottawatomie County, OK – September 2025 - Pioneer Library System is thrilled to announce engineer and former astronaut Leland Melvin as the 2025 keynote speaker for the annual Spark a Change ...

Pulse Biosciences (Nasdaq:PLSE) announced today that the FDA granted investigational device exemption (IDE) for its nanosecond pulsed field ablation (nsPFA) system. The approval allows Pulse to ...

Billionaire couple lists most expensive home in US for sale. See price. As Noem confirms more ICE resources are heading to Chicago, mayor is defying crackdown Bob the Drag Queen thought David ...

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ...

The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology ...

EINDHOVEN, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, ...